- Case Report
Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?
- Timothy Phan,
- Kurvi Patwala,
- Lara Lipton,
- Virginia Knight,
- Ahmad Aga and
- Stephen Pianko
Immune checkpoint inhibitors (ICIs) have led to major therapeutic advances in the management of malignancy. Despite promising outcomes for some cancers, ICIs are linked to unique side-effects known as immune-related adverse events (IrAEs). These may...

